INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $278,000 | -80.0% | 16,248 | -75.6% | 0.00% | -100.0% |
| Q1 2021 | $1,389,000 | -8.8% | 66,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,523,000 | +37.6% | 66,500 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $1,107,000 | +24.2% | 67,900 | +3.2% | 0.00% | 0.0% |
| Q2 2020 | $891,000 | +20.1% | 65,800 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $742,000 | -52.3% | 62,600 | +0.3% | 0.00% | 0.0% |
| Q4 2019 | $1,554,000 | +101.6% | 62,400 | +37.7% | 0.00% | 0.0% |
| Q3 2019 | $771,000 | -9.4% | 45,300 | +21.1% | 0.00% | 0.0% |
| Q2 2019 | $851,000 | -27.1% | 37,400 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $1,167,000 | +407.4% | 36,300 | +491.3% | 0.00% | – |
| Q2 2018 | $230,000 | -65.4% | 6,139 | -63.7% | 0.00% | -100.0% |
| Q1 2018 | $664,000 | -11.0% | 16,907 | -26.6% | 0.00% | 0.0% |
| Q4 2017 | $746,000 | +9.7% | 23,033 | +5.5% | 0.00% | 0.0% |
| Q3 2017 | $680,000 | +161.5% | 21,833 | +134.8% | 0.00% | – |
| Q2 2017 | $260,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,332,773 | $27,828,000 | 5.75% |
| First Light Asset Management, LLC | 2,036,645 | $42,525,000 | 2.82% |
| Altium Capital Management LP | 141,856 | $2,962,000 | 0.82% |
| PURA VIDA INVESTMENTS, LLC | 909,660 | $18,994,000 | 0.54% |
| Rock Springs Capital Management LP | 1,080,200 | $22,555,000 | 0.49% |
| Novo Holdings A/S | 508,922 | $10,626,000 | 0.44% |
| Davide Leone & Partners Investment Co Ltd. | 109,240 | $2,281,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 256,800 | $5,362,000 | 0.15% |
| Bellevue Group AG | 617,968 | $12,903,000 | 0.14% |
| Gyon Technologies Capital Management, LP | 13,318 | $278,000 | 0.12% |